Whistleblower, a blog for attorneys, reports that AstraZeneca and Cephalon have both reached settlements with the US Department of Justice totaling $54 million. The companies were accused of deliberately underreporting Average Manufacturer Prices to public health programs. The government accused the companies of underpaying rebates owed to the states that caused the United States to be overcharged for its payments to the states for the Medicaid program.
